Akzo Nobel India is currently trading at Rs. 1327.95, up by 7.75 points or 0.59% from its previous closing of Rs 1320.20 on the BSE.
The scrip opened at Rs. 1321.00 and has touched a high and low of Rs. 1329.95 and Rs. 1320.15 respectively. So far 26 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 1548.70 on 10-Aug-2015 and a 52 week low of Rs. 1201.00 on 24-Aug-2015.
Last one week high and low of the scrip stood at Rs. 1355.00 and Rs. 1305.00 respectively. The current market cap of the company is Rs. 6205.59 crore.
The promoters holding in the company stood at 72.96% while Institutions and Non-Institutions held 10.58% and 16.45% respectively.
AkzoNobel and Atul have signed a Letter of Intent (LoI) to explore the feasibility of setting up a manufacturing joint venture (JV) for the production of monochloroacetic acid (MCA) in India. The two companies are planning to install a world scale MCA plant at Atul’s facility in Gujarat, subject to the necessary regulatory approvals, building on Atul’s status as a leading supplier of crop protection chemicals (which uses MCA as a key raw material) and AkzoNobel’s leading global position in MCA, with plants in the Netherlands, China, Japan and the US.
The intended joint venture will use chlorine and hydrogen manufactured by Atul to produce MCA, taking advantage of Atul’s existing infrastructure and AkzoNobel’s latest eco-friendly hydrogenation technology. The proposed facility will mainly serve the Indian MCA market, as well as meeting the captive requirements of Atul.
AkzoNobel India (previously known as ICI India) is engaged in manufacturing and marketing of paints, speciality chemicals and adhesives.
| Company Name | CMP |
|---|---|
| Asian Paints | 2463.40 |
| Berger Paints India | 468.80 |
| Kansai Nerolac Paint | 203.05 |
| JSW Dulux | 2930.65 |
| Indigo Paints | 839.55 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: